The role of neoadjuvant chemoterapy in choosing the type of surgery in breast cancer HER2+ and triple negative. Issue 4 (April 2018) - Calderoni, S.; Brulatti, M.; Cuoghi, M.; Galluzzo, V.; Ferrarini, R.; Zanarini, D.; Cucchi, M.C.